<DOC>
	<DOC>NCT02893098</DOC>
	<brief_summary>A Multi-Centre, Parallel, Double-Blind, Active comparator, Randomised phase III Clinical Trial</brief_summary>
	<brief_title>A Study to Evaluate the Safety and Efficacy of Humia Inj. in Patients With Symptomatic Osteoarthritis of the Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<criteria>Primary knee osteoarthritis confirmed clinically and radiologically according to American College of Rheumatology criteria have joint pain KellgrenLawrence Grade Ⅰ to Ⅲ confirmed radiologically within 6 months Knee pain under weightbearing pain(100mmVAS) greater than 40mm Able to walk without assistive devices Patients willing and able to provide signed informed consent after the nature of the study has been explained Exclusion criteria: Body Mass Index (BMI) &gt; 32 History of rheumatoid arthritis or other inflammatory arthritis in knee articular cavity Systemic Intravenous Steroid injection within 1 month, intraarticular corticosteroid injection within 3 months or hyaluronate injection within 6 months Has clinically severe tense effusion of the target knee diagnosed Positive according to Patella tap test Undergo Knee Replacement Surgery of the target knee</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>